RT Journal Article
SR Electronic
T1 Distinct gut and vaginal microbiota profile in women with Recurrent Implantation Failure and Unexplained Infertility
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.09.21251410
DO 10.1101/2021.02.09.21251410
A1 Nayna Patel
A1 Nidhi Patel
A1 Sejal Pal
A1 Neelam Nathani
A1 Ramesh Pandit
A1 Molina Patel
A1 Niket Patel
A1 Chaitanya Joshi
A1 Bhavin Parekh
YR 2021
UL http://medrxiv.org/content/early/2021/02/12/2021.02.09.21251410.abstract
AB Background Implantation failure limits the success rate of natural and in vitro fertilization (IVF)-assisted conceptions. Evidence suggests dysbiosis in the female reproductive tract impacts implantation failure. However, whether gut dysbiosis influences implantation failure and whether it accompanies reproductive tract dysbiosis remains unexplored.Method We recruited 11fertile women as the controls, and a cohort of 20 women diagnosed with implantation-failure associated infertility, which included 10 women diagnosed with recurrent implantation failure (RIF), and 10 women diagnosed with unexplained infertility (UE). Using next-generation amplicon sequencing, we compared the diversity, structure, and composition of fecal and vaginal bacteria of the controls with that of the infertile cohort. While we sequenced fecal samples of all the participants (n=31), we could only sequence 8 vaginal samples in each group (n=24).Results Compared with the controls, α-diversity of the gut bacteria, analysed by Chao 1 and Shannon indices, among the infertile groups declined (p□<□0.05). β-diversity between the controls and infertile cohort, measured by both Bray-Curtis and Jaccard distances, differed significantly (p□<□0.05). Taxa analysis of the gut bacteria revealed enrichment of Gram-positive bacteria, mainly of the phylum Firmicutes, in the RIF group. In contrast, Gram-negative bacteria were relatively more abundant in the UE group. Additionally, mucus-producing bacteria genera such as Prevotella and Sutterella declined in the infertile cohort (p□<□0.05). Intriguingly, significant enrichment (p□<□0.05) of the genus Hungatella, associated with trimethylamine N-oxide (TMAO) production, occurred in the infertile cohort. Vaginal microbiota was dominated by L. iners across the groups, with the UE group showing the highest levels. Of the three groups, the RIF group had the least diverse vaginal microbiota. Taxa analysis showed higher levels of anaerobic bacteria such as Leptotrichia, Snethia, and Prevotella in the controls.Conclusion We posit that in the setting of the compromised gut mucosal barrier, the phyla Firmicutes generates TNF-α-driven systemic inflammation, leading to RIF, whereas an overload of Gram-negative bacteria induces IL-6-driven systemic inflammation, leading to UE. Additionally, Hungatella-induced elevation of TMAO levels causes platelet hypercoagulability, synergistically contributing to implantation failure. Finally, vaginal dysbiosis does not appear to co-occur with gut dysbiosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe clinical aspect of this work was funded by Dr. Nayna Patel, the director of Akanksha Hospital and Research Institute. The metagenomics aspect of the study was funded by Dr. Chaitanya Joshi, the director of Gujarat Biotechnology Research Centre (GBRC). We report no conflict of interest. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local Ethics Committee of Sat Kaival Hospital Pvt. Ltd (EC2013/053)on 25 September 2018.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe 16S rRNA gene sequencing data for all the gut and vaginal microbiota samples analyzed in this study have not been deposited with the National Center for Biotechnology Information.